StonvexLoading…
StonvexStonvexStonvexCore line items from NC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $277.20M | $237.71M | $214.79M | $241.72M |
Operating Income | $21.98M | $35.70M | $-70.14M | $69.99M |
Net Income | $17.57M | $33.74M | $-39.59M | $74.16M |
EPS (Diluted) | $2.35 | $4.55 | $-5.29 | $10.06 |
Total Assets | $661.23M | $631.69M | $539.71M | $568.07M |
Total Liabilities | $231.99M | $226.74M | $157.37M | $141.11M |
Cash & Equivalents | $49.71M | $72.83M | $85.11M | $110.75M |
Free Cash Flow OCF − CapEx | $2.28M | $-32.42M | $9.08M | $25.21M |
Shares Outstanding | 7.48M | 7.41M | 7.48M | 7.37M |